Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0.

Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0.

<p>Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0.</p>

保存先:

書誌詳細
第一著者:	Shelby S. Fisher (22676406) (author)
その他の著者:	Arnstein Lindaas (22676409) (author), Stella G. Muthuri (5395769) (author), Patricia C. Lloyd (18453529) (author), Joann F. Gruber (18453535) (author), Morgan M. Richey (21253213) (author), Hai Lyu (22676412) (author), Angela S. Cheng (22676415) (author), Lisa S. Kowarski (22676418) (author), Mollie M. McKillop (9111996) (author), Christine Bui (21253201) (author), Tainya C. Clarke (12892921) (author), Jeffrey Beers (22676421) (author), Timothy Burrell (12892927) (author), Pablo Freyria Duenas (22676424) (author), Yangping Chen (16549866) (author), Minya Sheng (22676427) (author), Richard A. Forshee (18453553) (author), Steven A. Anderson (11865398) (author), Yoganand Chillarige (18453556) (author), Mary S. Anthony (13922319) (author), Azadeh Shoaibi (11060528) (author), J. Bradley Layton (9756019) (author)
出版事項:	2025
主題:	Medicine Neuroscience Biotechnology Immunology Cancer Mental Health Infectious Diseases Environmental Sciences not elsewhere classified weighted hazard ratios still consistently elevated potential adverse events coronavirus disease 2019 contextualize united states 78 &# 8211 60 &# 8211 45 &# 8211 23 &# 8211 20 &# 8211 18 &# 8211 04 &# 8211 mediated adverse events vaccine safety surveillance postexposure reference windows 01 &# 8211 controlled risk interval mediated aes cannot aes included guillain xlink "> neurologic xlink "> covid xlink "> mediated conditions surveillance findings risk windows included adults 01 ). remaining aes transverse myelitis study period study observed service data relative incidences medicare fee matched comparators inverse probability increased risks increased risk generally modest data sources consistent evidence confidence intervals commercial database barré syndrome 28 ).
タグ:	タグ追加タグなし, このレコードへの初めてのタグを付けませんか!

このレコードへの初めてのコメントを付けませんか!

Cannot write session to /tmp/vufind_sessions/sess_nobg4ahele0u2ru1snkpmrci1b